Technical Analysis for SCPH - scPharmaceuticals Inc.

Grade Last Price % Change Price Change
F 5.49 -5.83% -0.34
SCPH closed down 5.83 percent on Monday, March 18, 2024, on 80 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
Bullish Engulfing Bullish -5.83%
Crossed Above 20 DMA Bullish -5.83%
Crossed Above 50 DMA Bullish -5.83%
Expansion Pivot Buy Setup Bullish Swing Setup -5.83%
Pocket Pivot Bullish Swing Setup -5.83%
Wide Range Bar Range Expansion -5.83%

   Recent Intraday Alerts

Alert Time
Up 2% about 17 hours ago
Up 1% about 17 hours ago
Possible Inside Day about 18 hours ago
50 DMA Support about 19 hours ago
10 DMA Support about 20 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

scPharmaceuticals Inc. Description

ScPharmaceuticals, Inc. is a United States-based biopharmaceutical company. The Company is engaged in developing pharmaceutical products for subcutaneous delivery. The Company offers sc2Wear Infusor, which is a small pump that attaches to the body using a standard medical adhesive. The sc2Wear Infusor injects the drug into the body slowly, similar to an intravenous (IV) drip. The sc2Wear Infusor includes features, such as two-component design, automated safety features and micropiston pump technology. Its pipeline includes product timelines for preclinical, through regulatory approval. Its products will be administered subcutaneously through the sc2Wear Infusor. Its lead products are subcutaneous formulations of furosemide (parenteral diuretic in treating heart failure) and ceftriaxone (parenteral antibiotic outside the hospital setting). Its furosemide formulation has been optimized for use with the sc2Wear Infusor. Its pipeline also includes Ertapenem for subcutaneous delivery.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Drugs Medication Pharmaceutical Products Chemical Compounds Antibiotics Heart Failure Chloroarenes Injection Intravenous Fluids Intravenous Therapy

Is SCPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 12.7311
52 Week Low 4.63
Average Volume 240,513
200-Day Moving Average 6.90
50-Day Moving Average 5.63
20-Day Moving Average 5.72
10-Day Moving Average 5.55
Average True Range 0.42
RSI (14) 47.09
ADX 22.58
+DI 20.15
-DI 15.30
Chandelier Exit (Long, 3 ATRs) 5.29
Chandelier Exit (Short, 3 ATRs) 6.20
Upper Bollinger Bands 6.29
Lower Bollinger Band 5.16
Percent B (%b) 0.29
BandWidth 19.67
MACD Line -0.04
MACD Signal Line 0.00
MACD Histogram -0.0358
Fundamentals Value
Market Cap 196.87 Million
Num Shares 35.9 Million
EPS -1.36
Price-to-Earnings (P/E) Ratio -4.04
Price-to-Sales 25.73
Price-to-Book 3.93
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.23
Resistance 3 (R3) 6.30 6.12 6.10
Resistance 2 (R2) 6.12 5.94 6.09 6.06
Resistance 1 (R1) 5.81 5.82 5.72 5.74 6.02
Pivot Point 5.63 5.63 5.59 5.60 5.63
Support 1 (S1) 5.32 5.45 5.23 5.25 4.96
Support 2 (S2) 5.14 5.33 5.11 4.92
Support 3 (S3) 4.83 5.14 4.88
Support 4 (S4) 4.76